Alector, Inc. (ALEC) Stock Ticker
ALEC right now
Market factors today
Unlock the full ALEC picture
About Alector, Inc.
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
ALEC stock facts
| Ticker symbol | ALEC |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $216.5M |
| CEO | Arnon Rosenthal |
| Employees | 103 |
| Headquarters | South San Francisco, CA, US |
| IPO date | 2019-02-07 |
| Website | www.alector.com |
What you can see for ALEC on Tickr
Live ALEC price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ALEC report.
Rankings
FAQ
What is the ticker symbol for Alector, Inc.?
The ticker symbol for Alector, Inc. is ALEC, listed on the NASDAQ Global Select.
What is ALEC?
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are…